NCT06731595View on ClinicalTrials.gov

Post-Ablation Pericarditis Reduction Study (PAPERS)

PHASE2CompletedINTERVENTIONAL

Enrollment

248

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

October 1, 2022

Conditions

Atrial FibrillationCatheter AblationPericarditis

Interventions

DRUG

Colchicine

colchicine 0.6mg oral twice daily for 7 days

Trial Locations (1)

46260

Ascension St Vincent Hospital, Indianapolis

All Listed Sponsors

collaborator

Asenson Sacred Heart - Pensacoloa, FL

UNKNOWN

lead

St. Vincent Cardiovascular Research Institute

OTHER